US 11866727
Materials and methods for treatment of glycogen storage disease type 1A
granted A61KA61K38/00
Quick answer
US patent 11866727 (Materials and methods for treatment of glycogen storage disease type 1A) held by CRISPR THERAPEUTICS AG expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/00